KUMULUS VAPE (ALVAP.PA) Stock Fundamental Analysis

EPA:ALVAP • FR0013419876

3.78 EUR
-0.02 (-0.53%)
Last: Feb 13, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

6

Taking everything into account, ALVAP scores 6 out of 10 in our fundamental rating. ALVAP was compared to 60 industry peers in the Specialty Retail industry. While ALVAP has a great health rating, its profitability is only average at the moment. ALVAP has a valuation in line with the averages, but it does not seem to be growing. Finally ALVAP also has an excellent dividend rating. These ratings could make ALVAP a good candidate for dividend investing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year ALVAP was profitable.
  • In the past year ALVAP has reported a negative cash flow from operations.
  • ALVAP had positive earnings in each of the past 5 years.
  • ALVAP had negative operating cash flow in 4 of the past 5 years.
ALVAP.PA Yearly Net Income VS EBIT VS OCF VS FCFALVAP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 9.80%, ALVAP belongs to the top of the industry, outperforming 85.00% of the companies in the same industry.
  • ALVAP's Return On Equity of 16.02% is fine compared to the rest of the industry. ALVAP outperforms 73.33% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 12.74%, ALVAP belongs to the top of the industry, outperforming 81.67% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for ALVAP is above the industry average of 10.21%.
Industry RankSector Rank
ROA 9.8%
ROE 16.02%
ROIC 12.74%
ROA(3y)9.89%
ROA(5y)10.27%
ROE(3y)16.02%
ROE(5y)15.99%
ROIC(3y)13.64%
ROIC(5y)14.38%
ALVAP.PA Yearly ROA, ROE, ROICALVAP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • The Profit Margin of ALVAP (4.35%) is better than 71.67% of its industry peers.
  • ALVAP's Profit Margin has improved in the last couple of years.
  • The Operating Margin of ALVAP (5.89%) is better than 68.33% of its industry peers.
  • ALVAP's Operating Margin has improved in the last couple of years.
  • With a Gross Margin value of 23.53%, ALVAP is not doing good in the industry: 73.33% of the companies in the same industry are doing better.
  • ALVAP's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.89%
PM (TTM) 4.35%
GM 23.53%
OM growth 3Y0.64%
OM growth 5Y19.19%
PM growth 3Y4.02%
PM growth 5Y42.75%
GM growth 3Y5.68%
GM growth 5Y0.12%
ALVAP.PA Yearly Profit, Operating, Gross MarginsALVAP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 5 10 15 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so ALVAP is creating value.
  • Compared to 1 year ago, ALVAP has about the same amount of shares outstanding.
  • Compared to 5 years ago, ALVAP has more shares outstanding
  • Compared to 1 year ago, ALVAP has an improved debt to assets ratio.
ALVAP.PA Yearly Shares OutstandingALVAP.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 1M 2M 3M
ALVAP.PA Yearly Total Debt VS Total AssetsALVAP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

  • An Altman-Z score of 4.49 indicates that ALVAP is not in any danger for bankruptcy at the moment.
  • ALVAP has a better Altman-Z score (4.49) than 90.00% of its industry peers.
  • ALVAP has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
  • ALVAP's Debt to Equity ratio of 0.21 is amongst the best of the industry. ALVAP outperforms 85.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Altman-Z 4.49
ROIC/WACC1.85
WACC6.89%
ALVAP.PA Yearly LT Debt VS Equity VS FCFALVAP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

2.3 Liquidity

  • A Current Ratio of 3.30 indicates that ALVAP has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 3.30, ALVAP belongs to the best of the industry, outperforming 91.67% of the companies in the same industry.
  • ALVAP has a Quick Ratio of 1.76. This is a normal value and indicates that ALVAP is financially healthy and should not expect problems in meeting its short term obligations.
  • ALVAP has a Quick ratio of 1.76. This is amongst the best in the industry. ALVAP outperforms 91.67% of its industry peers.
Industry RankSector Rank
Current Ratio 3.3
Quick Ratio 1.76
ALVAP.PA Yearly Current Assets VS Current LiabilitesALVAP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • ALVAP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -21.52%.
  • The Earnings Per Share has been growing by 97.48% on average over the past years. This is a very strong growth
  • Looking at the last year, ALVAP shows a very negative growth in Revenue. The Revenue has decreased by -34.12% in the last year.
  • Measured over the past years, ALVAP shows a very strong growth in Revenue. The Revenue has been growing by 41.89% on average per year.
EPS 1Y (TTM)-21.52%
EPS 3Y20.5%
EPS 5Y97.48%
EPS Q2Q%-23.21%
Revenue 1Y (TTM)-34.12%
Revenue growth 3Y20.74%
Revenue growth 5Y41.89%
Sales Q2Q%-51.16%

3.2 Future

  • ALVAP is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -1.02% yearly.
  • The Revenue is expected to decrease by -0.11% on average over the next years.
EPS Next Y-34.55%
EPS Next 2Y-4.02%
EPS Next 3Y-1.02%
EPS Next 5YN/A
Revenue Next Year-6.25%
Revenue Next 2Y-0.99%
Revenue Next 3Y-0.11%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALVAP.PA Yearly Revenue VS EstimatesALVAP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
ALVAP.PA Yearly EPS VS EstimatesALVAP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 4.67 indicates a rather cheap valuation of ALVAP.
  • Based on the Price/Earnings ratio, ALVAP is valued cheaper than 98.33% of the companies in the same industry.
  • ALVAP is valuated cheaply when we compare the Price/Earnings ratio to 26.68, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 6.80, the valuation of ALVAP can be described as very cheap.
  • Based on the Price/Forward Earnings ratio, ALVAP is valued cheaply inside the industry as 90.00% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of ALVAP to the average of the S&P500 Index (28.06), we can say ALVAP is valued rather cheaply.
Industry RankSector Rank
PE 4.67
Fwd PE 6.8
ALVAP.PA Price Earnings VS Forward Price EarningsALVAP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 96.67% of the companies in the same industry are more expensive than ALVAP, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.39
ALVAP.PA Per share dataALVAP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

  • The decent profitability rating of ALVAP may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.05
EPS Next 2Y-4.02%
EPS Next 3Y-1.02%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. Dividend

5.1 Amount

  • ALVAP has a Yearly Dividend Yield of 4.47%, which is a nice return.
  • Compared to an average industry Dividend Yield of 1.36, ALVAP pays a better dividend. On top of this ALVAP pays more dividend than 91.67% of the companies listed in the same industry.
  • ALVAP's Dividend Yield is rather good when compared to the S&P500 average which is at 1.84.
Industry RankSector Rank
Dividend Yield 4.47%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years2
ALVAP.PA Yearly Dividends per shareALVAP.PA Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.05 0.1 0.15

5.3 Sustainability

  • ALVAP pays out 17.40% of its income as dividend. This is a sustainable payout ratio.
DP17.4%
EPS Next 2Y-4.02%
EPS Next 3Y-1.02%
ALVAP.PA Yearly Income VS Free CF VS DividendALVAP.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 0 2M -2M 4M
ALVAP.PA Dividend Payout.ALVAP.PA Dividend Payout, showing the Payout Ratio.ALVAP.PA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

KUMULUS VAPE

EPA:ALVAP (2/13/2026, 7:00:00 PM)

3.78

-0.02 (-0.53%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners36.98%
Ins Owner ChangeN/A
Market Cap11.45M
Revenue(TTM)60.68M
Net Income(TTM)2.64M
Analysts86.67
Price Target7.04 (86.24%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.47%
Yearly Dividend0.15
Dividend Growth(5Y)N/A
DP17.4%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-4.17%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)25.58%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 4.67
Fwd PE 6.8
P/S 0.19
P/FCF N/A
P/OCF N/A
P/B 0.7
P/tB 0.86
EV/EBITDA 2.39
EPS(TTM)0.81
EY21.43%
EPS(NY)0.56
Fwd EY14.71%
FCF(TTM)-0.48
FCFYN/A
OCF(TTM)-0.36
OCFYN/A
SpS20.03
BVpS5.44
TBVpS4.42
PEG (NY)N/A
PEG (5Y)0.05
Graham Number9.96
Profitability
Industry RankSector Rank
ROA 9.8%
ROE 16.02%
ROCE 17.82%
ROIC 12.74%
ROICexc 17.68%
ROICexgc 22.48%
OM 5.89%
PM (TTM) 4.35%
GM 23.53%
FCFM N/A
ROA(3y)9.89%
ROA(5y)10.27%
ROE(3y)16.02%
ROE(5y)15.99%
ROIC(3y)13.64%
ROIC(5y)14.38%
ROICexc(3y)17.75%
ROICexc(5y)21.73%
ROICexgc(3y)22.02%
ROICexgc(5y)24.77%
ROCE(3y)19.12%
ROCE(5y)20.26%
ROICexgc growth 3Y1.55%
ROICexgc growth 5Y9.12%
ROICexc growth 3Y-5.62%
ROICexc growth 5Y6.22%
OM growth 3Y0.64%
OM growth 5Y19.19%
PM growth 3Y4.02%
PM growth 5Y42.75%
GM growth 3Y5.68%
GM growth 5Y0.12%
F-Score3
Asset Turnover2.25
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Debt/EBITDA 0.82
Cap/Depr 57.64%
Cap/Sales 0.57%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.3
Quick Ratio 1.76
Altman-Z 4.49
F-Score3
WACC6.89%
ROIC/WACC1.85
Cap/Depr(3y)181.05%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.97%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-21.52%
EPS 3Y20.5%
EPS 5Y97.48%
EPS Q2Q%-23.21%
EPS Next Y-34.55%
EPS Next 2Y-4.02%
EPS Next 3Y-1.02%
EPS Next 5YN/A
Revenue 1Y (TTM)-34.12%
Revenue growth 3Y20.74%
Revenue growth 5Y41.89%
Sales Q2Q%-51.16%
Revenue Next Year-6.25%
Revenue Next 2Y-0.99%
Revenue Next 3Y-0.11%
Revenue Next 5YN/A
EBIT growth 1Y-24.22%
EBIT growth 3Y21.51%
EBIT growth 5Y69.12%
EBIT Next Year-5.88%
EBIT Next 3Y3.78%
EBIT Next 5YN/A
FCF growth 1Y-124.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-117.39%
OCF growth 3YN/A
OCF growth 5YN/A

KUMULUS VAPE / ALVAP.PA FAQ

What is the fundamental rating for ALVAP stock?

ChartMill assigns a fundamental rating of 6 / 10 to ALVAP.PA.


What is the valuation status of KUMULUS VAPE (ALVAP.PA) stock?

ChartMill assigns a valuation rating of 6 / 10 to KUMULUS VAPE (ALVAP.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for KUMULUS VAPE?

KUMULUS VAPE (ALVAP.PA) has a profitability rating of 6 / 10.


What are the PE and PB ratios of KUMULUS VAPE (ALVAP.PA) stock?

The Price/Earnings (PE) ratio for KUMULUS VAPE (ALVAP.PA) is 4.67 and the Price/Book (PB) ratio is 0.7.


Can you provide the financial health for ALVAP stock?

The financial health rating of KUMULUS VAPE (ALVAP.PA) is 7 / 10.